Benzinga's Top Downgrades

Analysts at Piper Jaffray downgraded MAKO Surgical (NASDAQ: MAKO) from “overweight” to “neutral.” The target price for MAKO Surgical has been raised from $26 to $30. MAKO Surgical's shares closed at $29.70 yesterday.

Analysts at Barclays downgraded ARIAD Pharmaceuticals (NASDAQ: ARIA) from “overweight” to “underweight.” The target price for ARIAD Pharmaceuticals has been lowered from $25 to $4. ARIAD Pharmaceuticals' shares closed at $5.83 yesterday.

Nomura downgraded Maxim Integrated Products (NASDAQ: MXIM) from “buy” to “neutral.” The target price for Maxim Integrated Products is set to $28. Maxim Integrated's shares closed at $29.22 yesterday.

Analysts at Ascendiant Capital downgraded Leapfrog Enterprises (NYSE: LF) from “buy” to “neutral.” The target price for Leapfrog Enterprises has been lowered from $12 to $8. Leapfrog's shares closed at $9.15 yesterday.